img

Global and United States Mitral Valve Disease Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and United States Mitral Valve Disease Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Mitral Valve Disease Market
This report focuses on global and United States Mitral Valve Disease market, also covers the segmentation data of other regions in regional level and county level.
The global Mitral Valve Disease revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Mitral Valve Disease revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Mitral Valve Disease include Bayer AG, Zydus Lifesciences Limited, Affluent Medical, Artivion, Inc., Valcare Medical, Corcym UK Limited, Pfizer Inc., Novartis AG and Teva Pharmaceutical Industries Ltd., etc. The global five biggest players hold a share of % in 2023.
Global Mitral Valve Disease Scope and Market Size
Mitral Valve Disease market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Mitral Valve Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Mitral Valve Disease market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Bayer AG
Zydus Lifesciences Limited
Affluent Medical
Artivion, Inc.
Valcare Medical
Corcym UK Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Medtronic plc
ShockWave Medical, Inc.
Braile Biomedica
Abbott Laboratories
Labcor Laboratorios Ltda
Edwards Lifesciences Corporation
Segment by Type
Mitral Valve Repair
Mitral Valve Replacement
Mitral Valve Therapeutics

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Mitral Valve Disease definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Mitral Valve Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Mitral Valve Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mitral Valve Disease revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Mitral Valve Disease Product Introduction
1.2 Global Mitral Valve Disease Outlook 2018 VS 2023 VS 2033
1.2.1 Global Mitral Valve Disease Market Size for the Year 2018-2033
1.2.2 United States Mitral Valve Disease Market Size for the Year 2018-2033
1.3 Mitral Valve Disease Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of United States Mitral Valve Disease in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Mitral Valve Disease Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.4 Mitral Valve Disease Market Dynamics
1.4.1 Mitral Valve Disease Industry Trends
1.4.2 Mitral Valve Disease Market Drivers
1.4.3 Mitral Valve Disease Market Challenges
1.4.4 Mitral Valve Disease Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Mitral Valve Disease by Type
2.1 Mitral Valve Disease Market Segment by Type
2.1.1 Mitral Valve Repair
2.1.2 Mitral Valve Replacement
2.1.3 Mitral Valve Therapeutics
2.2 Global Mitral Valve Disease Market Size by Type (2018, 2023 & 2033)
2.3 Global Mitral Valve Disease Market Size by Type (2018-2033)
2.4 United States Mitral Valve Disease Market Size by Type (2018, 2023 & 2033)
2.5 United States Mitral Valve Disease Market Size by Type (2018-2033)
3 Mitral Valve Disease by Application
3.1 Mitral Valve Disease Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Mitral Valve Disease Market Size by Application (2018, 2023 & 2033)
3.3 Global Mitral Valve Disease Market Size by Application (2018-2033)
3.4 United States Mitral Valve Disease Market Size by Application (2018, 2023 & 2033)
3.5 United States Mitral Valve Disease Market Size by Application (2018-2033)
4 Global Mitral Valve Disease Competitor Landscape by Company
4.1 Global Mitral Valve Disease Market Size by Company
4.1.1 Global Key Companies of Mitral Valve Disease, Ranked by Revenue (2023)
4.1.2 Global Mitral Valve Disease Revenue by Player (2018-2023)
4.2 Global Mitral Valve Disease Concentration Ratio (CR)
4.2.1 Mitral Valve Disease Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Mitral Valve Disease in 2023
4.2.3 Global Mitral Valve Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Mitral Valve Disease Head office and Area Served
4.4 Global Key Players of Mitral Valve Disease, Product and Application
4.5 Global Key Players of Mitral Valve Disease, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Mitral Valve Disease Market Size by Company
4.7.1 Key Players of Mitral Valve Disease in United States, Ranked by Revenue (2023)
4.7.2 United States Mitral Valve Disease Revenue by Players (2021, 2023 & 2023)
5 Global Mitral Valve Disease Market Size by Region
5.1 Global Mitral Valve Disease Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Mitral Valve Disease Market Size by Region (2018-2033)
5.2.1 Global Mitral Valve Disease Market Size by Region: 2018-2023
5.2.2 Global Mitral Valve Disease Market Size by Region (2024-2033)
6 Americas
6.1 Americas Mitral Valve Disease Market Size YoY Growth 2018-2033
6.2 Americas Mitral Valve Disease Market Size by Type
6.2.1 Americas Mitral Valve Disease Market Size by Type (2018-2023)
6.2.2 Americas Mitral Valve Disease Market Size by Type (2024-2033)
6.2.3 Americas Mitral Valve Disease Market Share by Type (2018-2033)
6.3 Americas Mitral Valve Disease Market Size by Application
6.3.1 Americas Mitral Valve Disease Market Size by Application (2018-2023)
6.3.2 Americas Mitral Valve Disease Market Size by Application (2024-2033)
6.3.3 Americas Mitral Valve Disease Market Share by Application (2018-2033)
6.4 Americas Mitral Valve Disease Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Mitral Valve Disease Market Size YoY Growth 2018-2033
7.2 EMEA Mitral Valve Disease Market Size by Type
7.2.1 EMEA Mitral Valve Disease Market Size by Type (2018-2023)
7.2.2 EMEA Mitral Valve Disease Market Size by Type (2024-2033)
7.2.3 EMEA Mitral Valve Disease Market Share by Type (2018-2033)
7.3 EMEA Mitral Valve Disease Market Size by Application
7.3.1 EMEA Mitral Valve Disease Market Size by Application (2018-2023)
7.3.2 EMEA Mitral Valve Disease Market Size by Application (2024-2033)
7.3.3 EMEA Mitral Valve Disease Market Share by Application (2018-2033)
7.4 EMEA Mitral Valve Disease Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Mitral Valve Disease Market Size YoY Growth 2018-2033
8.2 China Mitral Valve Disease Market Size by Type
8.2.1 China Mitral Valve Disease Market Size by Type (2018-2023)
8.2.2 China Mitral Valve Disease Market Size by Type (2024-2033)
8.2.3 China Mitral Valve Disease Market Share by Type (2018-2033)
8.3 China Mitral Valve Disease Market Size by Application
8.3.1 China Mitral Valve Disease Market Size by Application (2018-2023)
8.3.2 China Mitral Valve Disease Market Size by Application (2024-2033)
8.3.3 China Mitral Valve Disease Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Mitral Valve Disease Market Size YoY Growth 2018-2033
9.2 APAC Mitral Valve Disease Market Size by Type
9.2.1 APAC Mitral Valve Disease Market Size by Type (2018-2023)
9.2.2 APAC Mitral Valve Disease Market Size by Type (2024-2033)
9.2.3 APAC Mitral Valve Disease Market Share by Type (2018-2033)
9.3 APAC Mitral Valve Disease Market Size by Application
9.3.1 APAC Mitral Valve Disease Market Size by Application (2018-2023)
9.3.2 APAC Mitral Valve Disease Market Size by Application (2024-2033)
9.3.3 APAC Mitral Valve Disease Market Share by Application (2018-2033)
9.4 APAC Mitral Valve Disease Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bayer AG
10.1.1 Bayer AG Company Details
10.1.2 Bayer AG Business Overview
10.1.3 Bayer AG Mitral Valve Disease Introduction
10.1.4 Bayer AG Revenue in Mitral Valve Disease Business (2018-2023)
10.1.5 Bayer AG Recent Development
10.2 Zydus Lifesciences Limited
10.2.1 Zydus Lifesciences Limited Company Details
10.2.2 Zydus Lifesciences Limited Business Overview
10.2.3 Zydus Lifesciences Limited Mitral Valve Disease Introduction
10.2.4 Zydus Lifesciences Limited Revenue in Mitral Valve Disease Business (2018-2023)
10.2.5 Zydus Lifesciences Limited Recent Development
10.3 Affluent Medical
10.3.1 Affluent Medical Company Details
10.3.2 Affluent Medical Business Overview
10.3.3 Affluent Medical Mitral Valve Disease Introduction
10.3.4 Affluent Medical Revenue in Mitral Valve Disease Business (2018-2023)
10.3.5 Affluent Medical Recent Development
10.4 Artivion, Inc.
10.4.1 Artivion, Inc. Company Details
10.4.2 Artivion, Inc. Business Overview
10.4.3 Artivion, Inc. Mitral Valve Disease Introduction
10.4.4 Artivion, Inc. Revenue in Mitral Valve Disease Business (2018-2023)
10.4.5 Artivion, Inc. Recent Development
10.5 Valcare Medical
10.5.1 Valcare Medical Company Details
10.5.2 Valcare Medical Business Overview
10.5.3 Valcare Medical Mitral Valve Disease Introduction
10.5.4 Valcare Medical Revenue in Mitral Valve Disease Business (2018-2023)
10.5.5 Valcare Medical Recent Development
10.6 Corcym UK Limited
10.6.1 Corcym UK Limited Company Details
10.6.2 Corcym UK Limited Business Overview
10.6.3 Corcym UK Limited Mitral Valve Disease Introduction
10.6.4 Corcym UK Limited Revenue in Mitral Valve Disease Business (2018-2023)
10.6.5 Corcym UK Limited Recent Development
10.7 Pfizer Inc.
10.7.1 Pfizer Inc. Company Details
10.7.2 Pfizer Inc. Business Overview
10.7.3 Pfizer Inc. Mitral Valve Disease Introduction
10.7.4 Pfizer Inc. Revenue in Mitral Valve Disease Business (2018-2023)
10.7.5 Pfizer Inc. Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Details
10.8.2 Novartis AG Business Overview
10.8.3 Novartis AG Mitral Valve Disease Introduction
10.8.4 Novartis AG Revenue in Mitral Valve Disease Business (2018-2023)
10.8.5 Novartis AG Recent Development
10.9 Teva Pharmaceutical Industries Ltd.
10.9.1 Teva Pharmaceutical Industries Ltd. Company Details
10.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
10.9.3 Teva Pharmaceutical Industries Ltd. Mitral Valve Disease Introduction
10.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Mitral Valve Disease Business (2018-2023)
10.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.10 Medtronic plc
10.10.1 Medtronic plc Company Details
10.10.2 Medtronic plc Business Overview
10.10.3 Medtronic plc Mitral Valve Disease Introduction
10.10.4 Medtronic plc Revenue in Mitral Valve Disease Business (2018-2023)
10.10.5 Medtronic plc Recent Development
10.11 ShockWave Medical, Inc.
10.11.1 ShockWave Medical, Inc. Company Details
10.11.2 ShockWave Medical, Inc. Business Overview
10.11.3 ShockWave Medical, Inc. Mitral Valve Disease Introduction
10.11.4 ShockWave Medical, Inc. Revenue in Mitral Valve Disease Business (2018-2023)
10.11.5 ShockWave Medical, Inc. Recent Development
10.12 Braile Biomedica
10.12.1 Braile Biomedica Company Details
10.12.2 Braile Biomedica Business Overview
10.12.3 Braile Biomedica Mitral Valve Disease Introduction
10.12.4 Braile Biomedica Revenue in Mitral Valve Disease Business (2018-2023)
10.12.5 Braile Biomedica Recent Development
10.13 Abbott Laboratories
10.13.1 Abbott Laboratories Company Details
10.13.2 Abbott Laboratories Business Overview
10.13.3 Abbott Laboratories Mitral Valve Disease Introduction
10.13.4 Abbott Laboratories Revenue in Mitral Valve Disease Business (2018-2023)
10.13.5 Abbott Laboratories Recent Development
10.14 Labcor Laboratorios Ltda
10.14.1 Labcor Laboratorios Ltda Company Details
10.14.2 Labcor Laboratorios Ltda Business Overview
10.14.3 Labcor Laboratorios Ltda Mitral Valve Disease Introduction
10.14.4 Labcor Laboratorios Ltda Revenue in Mitral Valve Disease Business (2018-2023)
10.14.5 Labcor Laboratorios Ltda Recent Development
10.15 Edwards Lifesciences Corporation
10.15.1 Edwards Lifesciences Corporation Company Details
10.15.2 Edwards Lifesciences Corporation Business Overview
10.15.3 Edwards Lifesciences Corporation Mitral Valve Disease Introduction
10.15.4 Edwards Lifesciences Corporation Revenue in Mitral Valve Disease Business (2018-2023)
10.15.5 Edwards Lifesciences Corporation Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Mitral Valve Disease Market Size United States VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Mitral Valve Disease Market Trends
Table 3. Mitral Valve Disease Market Drivers
Table 4. Mitral Valve Disease Market Challenges
Table 5. Mitral Valve Disease Market Restraints
Table 6. Global Mitral Valve Disease Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. United States Mitral Valve Disease Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Mitral Valve Disease Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. United States Mitral Valve Disease Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Mitral Valve Disease, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Mitral Valve Disease Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Mitral Valve Disease Revenue Share by Player, 2018-2023
Table 13. Global Mitral Valve Disease Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mitral Valve Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Valve Disease as of 2023)
Table 15. Global Key Players of Mitral Valve Disease, Headquarters and Area Served
Table 16. Global Key Players of Mitral Valve Disease, Product and Application
Table 17. Global Key Players of Mitral Valve Disease, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Mitral Valve Disease in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Mitral Valve Disease Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. United States Mitral Valve Disease Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Mitral Valve Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Mitral Valve Disease Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Mitral Valve Disease Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Mitral Valve Disease Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Mitral Valve Disease Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Mitral Valve Disease Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Mitral Valve Disease Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Mitral Valve Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Mitral Valve Disease Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Mitral Valve Disease Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Mitral Valve Disease Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Mitral Valve Disease Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Mitral Valve Disease Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Mitral Valve Disease Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Mitral Valve Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Mitral Valve Disease Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Mitral Valve Disease Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Mitral Valve Disease Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Mitral Valve Disease Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Mitral Valve Disease Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Mitral Valve Disease Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Mitral Valve Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Mitral Valve Disease Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Mitral Valve Disease Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Mitral Valve Disease Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Mitral Valve Disease Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Mitral Valve Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Mitral Valve Disease Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Mitral Valve Disease Market Size by Region (2024-2033) & (US$ Million)
Table 51. Bayer AG Company Details
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Mitral Valve Disease Product
Table 54. Bayer AG Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Zydus Lifesciences Limited Company Details
Table 57. Zydus Lifesciences Limited Business Overview
Table 58. Zydus Lifesciences Limited Mitral Valve Disease Product
Table 59. Zydus Lifesciences Limited Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 60. Zydus Lifesciences Limited Recent Development
Table 61. Affluent Medical Company Details
Table 62. Affluent Medical Business Overview
Table 63. Affluent Medical Mitral Valve Disease Product
Table 64. Affluent Medical Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 65. Affluent Medical Recent Development
Table 66. Artivion, Inc. Company Details
Table 67. Artivion, Inc. Business Overview
Table 68. Artivion, Inc. Mitral Valve Disease Product
Table 69. Artivion, Inc. Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 70. Artivion, Inc. Recent Development
Table 71. Valcare Medical Company Details
Table 72. Valcare Medical Business Overview
Table 73. Valcare Medical Mitral Valve Disease Product
Table 74. Valcare Medical Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 75. Valcare Medical Recent Development
Table 76. Corcym UK Limited Company Details
Table 77. Corcym UK Limited Business Overview
Table 78. Corcym UK Limited Mitral Valve Disease Product
Table 79. Corcym UK Limited Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 80. Corcym UK Limited Recent Development
Table 81. Pfizer Inc. Company Details
Table 82. Pfizer Inc. Business Overview
Table 83. Pfizer Inc. Mitral Valve Disease Product
Table 84. Pfizer Inc. Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 85. Pfizer Inc. Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Mitral Valve Disease Product
Table 89. Novartis AG Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Teva Pharmaceutical Industries Ltd. Company Details
Table 92. Teva Pharmaceutical Industries Ltd. Business Overview
Table 93. Teva Pharmaceutical Industries Ltd. Mitral Valve Disease Product
Table 94. Teva Pharmaceutical Industries Ltd. Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Ltd. Recent Development
Table 96. Medtronic plc Company Details
Table 97. Medtronic plc Business Overview
Table 98. Medtronic plc Mitral Valve Disease Product
Table 99. Medtronic plc Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 100. Medtronic plc Recent Development
Table 101. ShockWave Medical, Inc. Company Details
Table 102. ShockWave Medical, Inc. Business Overview
Table 103. ShockWave Medical, Inc. Mitral Valve Disease Product
Table 104. ShockWave Medical, Inc. Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 105. ShockWave Medical, Inc. Recent Development
Table 106. Braile Biomedica Company Details
Table 107. Braile Biomedica Business Overview
Table 108. Braile Biomedica Mitral Valve Disease Product
Table 109. Braile Biomedica Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 110. Braile Biomedica Recent Development
Table 111. Abbott Laboratories Company Details
Table 112. Abbott Laboratories Business Overview
Table 113. Abbott Laboratories Mitral Valve Disease Product
Table 114. Abbott Laboratories Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 115. Abbott Laboratories Recent Development
Table 116. Labcor Laboratorios Ltda Company Details
Table 117. Labcor Laboratorios Ltda Business Overview
Table 118. Labcor Laboratorios Ltda Mitral Valve Disease Product
Table 119. Labcor Laboratorios Ltda Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 120. Labcor Laboratorios Ltda Recent Development
Table 121. Edwards Lifesciences Corporation Company Details
Table 122. Edwards Lifesciences Corporation Business Overview
Table 123. Edwards Lifesciences Corporation Mitral Valve Disease Product
Table 124. Edwards Lifesciences Corporation Revenue in Mitral Valve Disease Business (2018-2023) & (US$ Million)
Table 125. Edwards Lifesciences Corporation Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Mitral Valve Disease Product Picture
Figure 2. Global Mitral Valve Disease Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Mitral Valve Disease Market Size 2018-2033 (US$ Million)
Figure 4. United States Mitral Valve Disease Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. United States Mitral Valve Disease Market Size 2018-2033 (US$ Million)
Figure 6. United States Mitral Valve Disease Market Share in Global 2018-2033
Figure 7. Mitral Valve Disease Report Years Considered
Figure 8. Product Picture of Mitral Valve Repair
Figure 9. Product Picture of Mitral Valve Replacement
Figure 10. Product Picture of Mitral Valve Therapeutics
Figure 11. Global Mitral Valve Disease Market Share by Type in 2023 & 2033
Figure 12. Global Mitral Valve Disease Market Size by Type (2018-2033) & (US$ Million)
Figure 13. Global Mitral Valve Disease Market Share by Type (2018-2033)
Figure 14. United States Mitral Valve Disease Market Share by Type in 2023 & 2033
Figure 15. United States Mitral Valve Disease Market Size by Type (2018-2033) & (US$ Million)
Figure 16. United States Mitral Valve Disease Market Share by Type (2018-2033)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Ambulatory Surgical Centers
Figure 19. Product Picture of Others
Figure 20. Global Mitral Valve Disease Market Share by Application in 2023 & 2033
Figure 21. Global Mitral Valve Disease Market Size by Application (2018-2033) & (US$ Million)
Figure 22. Global Mitral Valve Disease Market Share by Application (2018-2033)
Figure 23. United States Mitral Valve Disease Market Share by Application in 2023 & 2033
Figure 24. United States Mitral Valve Disease Market Size by Application (2018-2033) & (US$ Million)
Figure 25. United States Mitral Valve Disease Market Share by Application (2018-2033)
Figure 26. The Top 5 and 10 Largest Companies of Mitral Valve Disease in the World: Market Share by Mitral Valve Disease Revenue in 2023
Figure 27. Global Mitral Valve Disease Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 28. Global Mitral Valve Disease Market Share by Region (2018-2033)
Figure 29. Americas Mitral Valve Disease Market Size Growth Rate 2018-2033 (US$ Million)
Figure 30. Americas Mitral Valve Disease Market Share by Type (2018-2033)
Figure 31. Americas Mitral Valve Disease Market Share by Application (2018-2033)
Figure 32. United States Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Canada Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Mexico Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Brazil Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. EMEA Mitral Valve Disease Market Size Growth Rate 2018-2033 (US$ Million)
Figure 37. EMEA Mitral Valve Disease Market Share by Type (2018-2033)
Figure 38. EMEA Mitral Valve Disease Market Share by Application (2018-2033)
Figure 39. Europe Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Middle East Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Africa Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Mitral Valve Disease Market Size Growth Rate 2018-2033 (US$ Million)
Figure 43. China Mitral Valve Disease Market Share by Type (2018-2033)
Figure 44. China Mitral Valve Disease Market Share by Application (2018-2033)
Figure 45. APAC Mitral Valve Disease Market Size Growth Rate 2018-2033 (US$ Million)
Figure 46. APAC Mitral Valve Disease Market Share by Type (2018-2033)
Figure 47. APAC Mitral Valve Disease Market Share by Application (2018-2033)
Figure 48. Japan Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. South Korea Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. China Taiwan Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Southeast Asia Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. India Mitral Valve Disease Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Bayer AG Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 54. Zydus Lifesciences Limited Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 55. Affluent Medical Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 56. Artivion, Inc. Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 57. Valcare Medical Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 58. Corcym UK Limited Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 59. Pfizer Inc. Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 62. Medtronic plc Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 63. ShockWave Medical, Inc. Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 64. Braile Biomedica Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 65. Abbott Laboratories Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 66. Labcor Laboratorios Ltda Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 67. Edwards Lifesciences Corporation Revenue Growth Rate in Mitral Valve Disease Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed